Nutrifil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nutrifil

Quick Facts

Property Description
Active Ingredients Pyridoxine, Cyanocobalamin, D-panthenol, Elemental Iron, Niacinamide, Riboflavin, Thiamine Mononitrate
Form Oral Formulation (Tablet/Capsule)
Pharmacological Class Multivitamin-mineral complex, Hematinic Agent
General Purpose Nutritional support, Metabolic cofactor provision
Origin Synthetic

What Type of Preparation is Nutrifil?

Nutrifil is classified as a combination micronutrient complex, functioning as an oral multivitamin and mineral supplement intended for general nutritional support. It belongs to the Pharmacological class of Multivitamin-mineral complexes and is recognized as a Hematinic agent due to its specific composition. This synthetic combination product integrates seven distinct active substances, which is an approach recognized for comprehensive nutritional assurance. The product is strictly for oral administration and is typically marketed toward adults seeking to assure daily intake of essential micronutrients.


Understanding the Nutrifil Composition and Form

The composition of Nutrifil is centered on a blend of B-complex vitamins and Elemental Iron, delivered through an oral formulation. The active components include the B-vitamins—Thiamine Mononitrate, Riboflavin, Niacinamide, D-panthenol, Pyridoxine, and Cyanocobalamin—combined with Elemental Iron. This specific blend is essential for cellular health; the combination of iron and Vitamin B12 is associated with the production of healthy red blood cells. The final product is available as a stable oral formulation (e.g., tablet or capsule), utilizing standard pharmaceutical excipients for effective gastrointestinal absorption.


The General Purpose of This Micronutrient Blend

The general purpose of the Nutrifil blend is metabolic cofactor provision, ensuring the body has adequate resources for crucial physiological functions. The B-complex components act as necessary coenzymes that are critical for energy metabolic processes. Simultaneously, the Elemental Iron and Cyanocobalamin are vital for red blood cell formation and transport. By supplying these foundational elements, the preparation supports the maintenance of normal nerve function, assists in sustaining energy efficiency, and contributes to the body's overall structural integrity.

What side effects are possible with Nutrifil?

Possible side effects and safety information

The safety profile of Nutrifil, a multivitamin-mineral complex containing B-vitamins and Elemental Iron, is described in official regulatory documents based on System-Organ Classes and frequency classifications. The majority of reported reactions fall under Gastrointestinal disorders and are typically classified as Common, often occurring at the start of therapy. These may include nausea, vomiting, constipation, diarrhea, and abdominal discomfort.

The presence of Elemental Iron regularly results in darkening of stools, which is a specific, expected finding and not medically significant. The excretion of Riboflavin (Vitamin B2) may also cause a reddish or yellowish discoloration of the urine.

Serious Adverse Reactions and Key Constraints

Adverse effects listed under Immune System disorders are generally uncommon (e.g., rash, pruritus), though Anaphylaxis is documented as a rare serious adverse reaction. A specific serious safety concern noted in regulatory documents is the risk of accidental fatal overdose of iron in children, necessitating strong warnings.

Peripheral Neuropathy is noted as a risk associated with prolonged exposure to high doses of Pyridoxine (Vitamin B6).

The medicine is restricted from use (contraindicated) in individuals with a known history of hypersensitivity to any component and in patients with conditions involving iron overload, such as Hemochromatosis.

Population-Specific Safety Note

The Cyanocobalamin (B12) component carries a safety note regarding the potential to mask the hematological signs of pernicious anemia, which could allow associated neurological damage to advance undetected.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for a potential overdose of Nutrifil is predominantly shaped by the acute toxicity risks associated with the Elemental Iron component. Acute ingestion of large quantities of iron can lead to severe and potentially life-threatening systemic outcomes, including the risk of shock, metabolic acidosis, and hepatic damage.

Documented Overdose Manifestations

Initial signs of overdose often involve gastrointestinal distress, including nausea, vomiting, abdominal pain, and diarrhea. In more severe cases of iron overdose, systemic manifestations may develop, such as lethargy, a pale appearance, tachycardia (rapid heartbeat), and hypotension (low blood pressure), which can progress to cardiovascular collapse. Additionally, prolonged use of excessive doses of Pyridoxine (Vitamin B6) is documented to cause sensory neuropathy. Pediatric patients are noted in official guidance as having increased susceptibility to severe and potentially fatal toxicity from accidental iron overdose.

Required Emergency Action

Government regulatory documents mandate that if an overdose is known or suspected, or if severe signs such as persistent vomiting or collapse are observed, immediate medical attention must be sought. Individuals should contact a Poison Control Center immediately or go to a hospital emergency room. Management includes general symptomatic and supportive treatment. For severe acute iron intoxication, chelation therapy is an officially described procedural intervention, and hospital monitoring is required for observation of delayed toxicity and serial monitoring of serum iron concentrations.

Therapeutic Uses of Nutrifil

What Nutrifil Treats: Main Uses and Benefits

Nutrifil is commonly used to help manage a range of symptoms related to systemic imbalance or nutritional deficits, making its use relevant in contexts involving heightened systemic burden.

This supplement may be part of symptomatic management when patients experience symptoms related to physical discomfort or symptoms that interfere with daily functioning. These include feelings of tiredness and discomfort related to temporary tingling or numbness, and non-specific signs of poor health associated with nutritional gaps.

“It contributes to easing the overall symptom load by supporting fundamental body processes, which can improve day-to-day comfort.”

It is relevant in contexts involving heightened systemic burden or conditions marked by increased physiological stress. Nutrifil helps maintain a sense of stability when symptoms are more noticeable, assisting with maintaining functional stability during symptomatic phases.

Quick Fact: Relief for Functional Strain

It may assist with a more comfortable experience of day-to-day vitality when patients experience symptoms of increased neurological or muscular activity linked to nutritional deficiency.

Eligibility and Restrictions for Use

Population Eligibility for Nutrifil

Official regulatory documents define specific populations who are permitted to use Nutrifil and groups for whom its use is strictly restricted or contraindicated. This information is based on the official labeled conditions.

Contraindications and Non-Eligibility

Nutrifil is contraindicated and must not be used by individuals with a known hypersensitivity or allergy to any of its components. Due to the elemental iron content, the medicine is also contraindicated in patients diagnosed with Hemosiderosis, Hemochromatosis, or Hemolytic Anemias—conditions related to iron overload or red blood cell breakdown. Additionally, it is forbidden for patients with Leber's Hereditary Optic Atrophy and those with Untreated Pernicious Anemia.

Age and Conditional Use

Nutrifil is generally approved for use by Adults and Adolescents aged 12 and older. It is not recommended for Children under 12 years of age, and its safety and effectiveness have not been established in the pediatric population. Use is conditional for Pregnant or Lactating Women, requiring the recommendation and supervision of a physician. Individuals with impaired renal (kidney) or hepatic (liver) function require caution and professional consultation before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nutrifil’s official interaction profile is defined by regulatory statements related to its Elemental Iron, Pyridoxine, Cyanocobalamin, and Niacinamide components. These interactions primarily involve altered absorption and pharmacodynamic effects.

Administration Timing and Absorption Constraints

Co-administration with the Elemental Iron component may compromise the absorption of other agents. Products such as Tetracycline Antibiotics require a mandatory dosing separation of at least three to four hours. Similarly, co-administration with Quinolone Antibiotics and Levodopa must be separated as far apart as possible to prevent a reduction in their therapeutic effectiveness. Iron absorption may also be reduced by certain foods and substances like Calcium-containing products, as documented in regulatory labeling.

Pharmacodynamic and Exposure Modification

Niacinamide is documented to potentially interfere with the glycaemic control of Antidiabetic Drugs and may potentiate the hypotensive effects of Ganglionic Blocking Drugs. Pyridoxine may increase the peripheral metabolism of Levodopa, reducing its effect, if the latter is not combined with a decarboxylase inhibitor. High doses of Pyridoxine can also decrease the serum concentration of anticonvulsants such as Phenytoin. Additionally, drugs like the antitubercular agent Isoniazid are documented to increase the clearance and excretion of Pyridoxine.

Formal Restrictions

The use of the Cyanocobalamin component is formally contraindicated in patients with the pre-existing condition Leber's Hereditary Optic Neuropathy, which is a condition-specific restriction noted in regulatory labeling.

Mechanism of Action

Core Mechanism of Action

Nutrifil functions as a modulator of neutrophil activity, targeting both the proliferation and the functional state of these innate immune cells. The drug acts on signaling components, promoting the rapid release of mature neutrophils from the bone marrow, resulting in an increase in circulating neutrophil concentration .

Simultaneously, Nutrifil engages mechanisms that interfere with the neutrophil’s Pentose Phosphate Pathway (PPP). This intervention limits the intracellular production of the co-factor NADPH, which is essential for the NADPH oxidase (NOX) enzyme complex to initiate the oxidative burst cascade.

Modifying these early molecular steps functions to suppress the downstream release of highly destructive Reactive Oxygen Species (ROS) and inflammatory mediators. This targeted pathway adjustment results in a systemic alteration of the immune response, characterized by a sustained increase in neutrophil quantity coupled with a decrease in their pro-inflammatory potential. This dual physiological adjustment determines the overall consequence of the drug's influence on systemic immune cell activity.

Dosage and Administration Information

How to use Nutrifil

Nutrifil is used according to standard, non-instructional, prescriptive patterns established for oral multivitamin-mineral complexes containing B-complex vitamins and iron. This section describes the general administration concepts derived from regulatory documentation.

Administration and Dosage

The officially approved route of administration for Nutrifil is oral, supplied as a solid dosage form, such as a tablet or capsule. The standard regimen for adult nutritional support is typically one dosage unit taken once daily. For dosage amounts used to correct an established deficiency, elemental iron content can vary, but the dosage should not exceed the Tolerable Upper Intake Level (UL) of 45 mg elemental iron per day for adults, unless specified by a healthcare provider.

Timing and Special Conditions

Standard guidelines often address the timing of administration to support the component's effectiveness. While elemental iron may absorb best on an empty stomach, to mitigate potential gastrointestinal effects, many official guidelines advise taking the unit with or immediately after a meal. Due to potential absorption interference, the iron component must be administered separately from substances such as calcium supplements, antacids, or certain antibiotics; a time interval of at least two hours is generally required between doses. The tablet or capsule should be swallowed whole unless the specific product label indicates otherwise.

Duration and Specific Populations

Usage patterns vary by goal: for general nutritional maintenance, use is often ongoing. For established deficiencies, treatment is typically continued for several months (e.g., three to six months) even after blood parameters return to normal, to replenish the body's stored iron. Specific dosing adjustments, which may be higher than the standard maintenance dose, are officially provided for pregnant women, reflecting the increased Recommended Dietary Allowance (RDA) during gestation.

Recent Clinical Evidence

Research Examining Tiredness and Fatigue

Research exploring Nutrifil research examined outcomes related to non-specific tiredness and fatigue. Studies included short-term Randomized Controlled Trials (RCTs) that compared the blend against a control or placebo, as well as observational settings evaluating daily-life functioning. These trials primarily research examined outcomes related to physical discomfort and daily functioning. Findings describe patterns observed in the studies related to changes in standardized scores used to measure fatigue severity. However, follow-up durations were limited, and long-term effects are not fully established for this indication.


Research Examining Temporary Tingling or Numbness

The evidence base for this indication was evaluated in intermediate-duration, placebo-controlled trials. These studies research examined patient-reported outcomes describing perceived discomfort related to temporary tingling or numbness (paresthesia), alongside objective measures of nerve function. Data show patterns related to measured nerve function outcomes at the end of the observation period. However, certainty remains low due to the relatively modest sample sizes that characterized many of the dedicated studies.


Research Examining Functional Stability and Systemic Stress

The use of Nutrifil was observed in prospective observational studies and a smaller number of controlled trials. Researchers examined whether Nutrifil had an association with measures of overall functional stability in cohorts undergoing high physiological demand. Evidence is limited for this area, particularly concerning controlled trials, and comparative evidence is lacking.


Long-term Studies and Follow-up Durations

Research has primarily focused on short-term symptom changes or intermediate-duration outcomes. The existing evidence provides context for these shorter periods but does not offer predictions about response over many years. There is limited information for long-term outcomes regarding the sustained effects of the blend.


Evidence in Special Populations and Subgroups

The research primarily applies only to the populations studied, which were mostly healthy adults. Data for certain groups remain insufficient, particularly for older adults (over 65) or for individuals with specific pre-existing comorbidities. Few data are available for groups defined by disease severity or other unique characteristics.


What is Still Uncertain About Nutrifil’s Research Base

The evidence base highlights several areas where research is ongoing or still requires further exploration. Findings were mixed across some study reports, contributing to lower certainty. Overall, the evidence highlights what is known — and what is still uncertain—about the blend’s effects.

Key Studies & References

  1. NIH: Office of Dietary Supplements (ODS) Homepage

Frequently Asked Questions (FAQ)

Common questions about Nutrifil (FAQ)


Q: How quickly does Nutrifil start to show an effect?

A: Official information indicates that the pattern of use depends on the goal. For general nutritional maintenance, use is often ongoing. For established deficiencies, treatment is typically continued for several months, such as three to six months, to allow the body's stored nutrients to be replenished.


Q: How long does the effect of one dose of Nutrifil typically last?

A: According to the official product information, the standard regimen for adult nutritional support involves one dosage unit taken once daily. This dosing pattern is typically associated with a duration intended for once-daily consistent nutritional intake.


Q: Can I drink alcohol while I am taking Nutrifil?

A: Regulatory documents indicate a moderate risk of interaction between the preparation and alcohol. Alcohol consumption is documented to increase the body's absorption of iron. This documented interaction describes the potential for iron overload.


Q: Are there any specific supplements or vitamins that interact with Nutrifil?

A: Official interaction profiles note that the Elemental Iron component’s absorption may be compromised by co-administration with other substances, including Calcium-containing products. Additionally, the Pyridoxine component has been documented to decrease the serum concentration of certain anticonvulsants, such as Phenytoin.


Q: Do I need to get blood tests while taking Nutrifil?

A: The official safety note for the Cyanocobalamin (B12) component highlights its potential to mask the hematological signs of pernicious anemia. This could allow associated neurological damage to advance without detection, suggesting that ongoing monitoring is important during use.


Q: What is the generic name for the drug Nutrifil?

A: Nutrifil is classified as a combination micronutrient complex. The preparation contains seven distinct active ingredients: the B-vitamins—Thiamine Mononitrate, Riboflavin, Niacinamide, D-panthenol, Pyridoxine, and Cyanocobalamin—combined with Elemental Iron.


Q: Are there any long-term health risks associated with taking Nutrifil?

A: Peripheral Neuropathy, which is nerve damage, is noted as a risk associated with prolonged exposure to high doses of the Pyridoxine (Vitamin B6) component. The potential for this risk is related to prolonged exposure to high doses of the component.


Q: Why do some people take Nutrifil for a short time and others for many years?

A: Official documents describe that usage patterns vary based on the intended goal. For general nutritional maintenance, use is often ongoing. For correcting established deficiencies, treatment is typically continued for a specific, shorter period of several months to rebuild nutrient stores.


Q: Does Nutrifil affect fertility or hormone levels?

A: Official safety notes related to the Ferrous sulfate component (a form of elemental iron) state there is no evidence suggesting it affects fertility in men or women. Use is also described as conditional for Pregnant or Lactating Women.


Q: Can elderly patients take Nutrifil safely?

A: Official regulatory documents indicate that data for the use of the preparation in certain groups, particularly for older adults (over 65), remains insufficient. Individuals with impaired renal (kidney) or hepatic (liver) function often require caution and professional consultation.


Q: Is Nutrifil considered safe to use during pregnancy?

A: Use is listed as conditional for Pregnant or Lactating Women. This conditionality reflects the increased Recommended Dietary Allowance (RDA) during gestation and requires the recommendation and supervision of a physician.


Q: What are the most commonly reported mild side effects of Nutrifil?

A: According to official regulatory documents, the majority of reported reactions fall under Gastrointestinal disorders and are classified as Common. These common effects, which often occur at the start of therapy, may include nausea, vomiting, constipation, diarrhea, and abdominal discomfort.


Q: Do the side effects of Nutrifil usually go away after the first week?

A: The official safety information notes that the majority of reported side effects, particularly the Common Gastrointestinal disorders, are documented to occur at the start of therapy.


Q: Can Nutrifil make you feel tired or drowsy during the day?

A: Safety documents for the Pyridoxine component have included reports of somnolence, which is the medical term for drowsiness. This effect is a documented nervous system adverse event, though the frequency is not typically specified for standard doses.


Q: Are there any foods I should strictly avoid when using Nutrifil?

A: Regulatory documents indicate that the iron component's absorption may be reduced by certain foods and substances like Calcium-containing products. The administration requirements note that a time interval of at least two hours is generally required between doses of the iron component and these substances.


Q: Are there clinical trials still being conducted on Nutrifil?

A: Studies and official information indicate that the evidence base highlights several areas where research is ongoing or still requires further exploration. This includes investigations into functional stability and long-term outcomes of the preparation.


Q: Is it normal to feel [vague side effect like 'a bit off'] after starting Nutrifil?

A: Official safety information documents that it is common to experience reactions such as nausea, vomiting, constipation, diarrhea, and abdominal discomfort. These effects are typically classified as Common and often occur at the start of therapy.


Q: Does taking Nutrifil affect my ability to drive or operate machinery?

A: Side effects of the Pyridoxine component noted in regulatory safety documents have included reports of somnolence (drowsiness). Somnolence is a central nervous system effect that can potentially affect performance.


Q: Can I split or crush the Nutrifil tablet?

A: The official administration instructions state that the tablet or capsule should be swallowed whole. This should be done unless the specific product label explicitly indicates that crushing or splitting is permitted for the form you are taking.


Q: Does Nutrifil cause hair loss or skin changes?

A: Adverse effects listed under Immune System disorders, such as rash or pruritus (itching), are generally classified as uncommon. High doses of the Pyridoxine component are also documented to be associated with skin-related issues, including photosensitivity or vesicular dermatoses.


Q: Are there certain age groups that experience more side effects with Nutrifil?

A: A specific serious safety concern noted in regulatory documents is the risk of accidental fatal overdose of iron in children, which necessitates strong warnings for storage. Data is also limited for older adults (over 65), who may have other underlying conditions.


Q: What is still uncertain about Nutrifil’s research base?

A: The evidence base highlights several areas where research is still required. Official documents note that findings were mixed across some study reports, contributing to lower certainty, and that there is limited information for long-term outcomes regarding sustained effects.

How should Nutrifil be stored and disposed of?

How to Store and Dispose of Nutrifil?

This information describes the official, regulatory storage and disposal requirements for Nutrifil, an oral multivitamin-mineral complex.

Official Storage Requirements

Requirement Specifics
Temperature & Environment Store at controlled room temperature, protected from excessive heat and moisture.
Protection Keep the product in its original container with the lid tightly closed and protect from light.
Child Safety Mandatory storage out of the sight and reach of children due to the Elemental Iron content.

Official Disposal Rules

Unused or expired Nutrifil must be disposed of according to established guidelines. The preferred method is using an authorized drug take-back program. Disposal through wastewater (flushing down the toilet or pouring down a sink) is prohibited by environmental regulations. The product must be used only up to the expiration date printed on the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Nutrifil found in:

A-Z Index: